Skip to main content
Equibles

UBS Group AG

Position in GOVX — GeoVax Labs, Inc.

CIK 1610520 ZURICH, V8
Back to GOVX Full portfolio

Position in GOVX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,198
-$4,664 QoQ
Shares Held
944
-77.8% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 17 holders
Holding Since
Dec 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GOVX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. GOVX ranks #509 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in GOVX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,198 944
2026-03-31 $5,862 4,248
2025-12-31 $15,303 89,501
2025-09-30 $27,635 58,428
2025-06-30 $173,421 200,257
2025-03-31 $96,961 91,473
2024-12-31 $69,947 28,319
2024-09-30 $2,749 1,141
2023-09-30 $9,775 19,019
2023-06-30 $398 725
2023-03-31 $9,708 14,599
2022-06-30 $3,499 4,216
2021-12-31 $16,297 4,502
2021-09-30 $7,849 1,817
2020-12-31 $6,932 2,051